Conclusions The clinical use of dupilumab, as well as selective anti-IL-13 drugs, has shown that blocking IL-13 is effective both for the treatment of asthma and atopic dermatitis and may be of use in other atopic conditions (e
Conclusions The clinical use of dupilumab, as well as selective anti-IL-13 drugs, has shown that blocking IL-13 is effective both for the treatment of asthma and atopic dermatitis and may be of use in other atopic conditions (e.g., severe contact allergy). several functional systems. Results: Prolonged repression of IL-13 in several thousand patients so far […]